Related Articles
Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer (Review)
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)
Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)
The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review)
Statins and pancreatic cancer (Review)